Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Seymour

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Cancer Treatment Reviews|September 5, 1998
Colorectal cancer: treatment of advanced diseaseM T Seymour
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1992
Ambulatory chemotherapyM T Seymour, M L Slevin
The British Journal of Clinical Practice|June 1, 1987
Free fall from twelve storeys with survivalM T Seymour, J B Phillips, G Mann
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2009
Concomitant medications in cancer patients: should we be more active in their management?S Lord, P S Hall, M T Seymour
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1997
Attitudes and practice in the management of metastatic colorectal cancer in Britain. Colorectal Cancer Working Party of the UK Medical Research CouncilM T Seymour, S P Stenning, J Cassidy
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2009
Are we representing the true population in oncology trials?S R Lord, P S Hall, M T Seymour
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2020
Are we representing the true population in oncology trials?S R Lord, P S Hall, M T Seymour
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 24, 2005
Intravenous irinotecan plus oral ciclosporinN S Vasudev, S Jagdev, D A Anthoney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
What can the molecular pathologist offer for optimal decision making?S D Richman, G G A Hutchins, M T Seymour, et al.
British Journal of Cancer|November 20, 2002
Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancerP Leonard, M T Seymour, R James, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Cancer Treatment Reviews|September 5, 1998
Colorectal cancer: treatment of advanced diseaseM T Seymour
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1992
Ambulatory chemotherapyM T Seymour, M L Slevin
The British Journal of Clinical Practice|June 1, 1987
Free fall from twelve storeys with survivalM T Seymour, J B Phillips, G Mann
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2009
Concomitant medications in cancer patients: should we be more active in their management?S Lord, P S Hall, M T Seymour
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1997
Attitudes and practice in the management of metastatic colorectal cancer in Britain. Colorectal Cancer Working Party of the UK Medical Research CouncilM T Seymour, S P Stenning, J Cassidy
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2009
Are we representing the true population in oncology trials?S R Lord, P S Hall, M T Seymour
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2020
Are we representing the true population in oncology trials?S R Lord, P S Hall, M T Seymour
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 24, 2005
Intravenous irinotecan plus oral ciclosporinN S Vasudev, S Jagdev, D A Anthoney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
What can the molecular pathologist offer for optimal decision making?S D Richman, G G A Hutchins, M T Seymour, et al.
British Journal of Cancer|November 20, 2002
Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancerP Leonard, M T Seymour, R James, et al.
Pageof 4